Industry News

In a historic vote to reschedule cannabis and cannabis resin, The United Nations Commission on Narcotic Drugs (CND) recently accepted the recommendation from the World Health Organization (WHO).


It was a very close call, with 27 votes in favour, 25 votes against, and 1 abstention.


This rescheduling of cannabis and cannabis resin may have significant positive impacts on the global cannabis industry in terms of how it is regulated and researched as medicinal remedies.


“The medical cannabis wave has accelerated in recent years already, but this will give it a boost,” stated Martin Jelsma, director of the drugs and democracy program at Transnational Institute, located in the Netherlands. “And for those countries that basically mirror the U.N. scheduling in their domestic legislation, it may lead to national descheduling and remove obstacles to use cannabis for medical and research purposes.


With the entire world gradually waking up to the realization of cannabis’ health benefits, this new vote could lead to the reevaluation of how cannabis is scheduled and categorized on the narcotic drug lists of countries across the globe. The end result may mean increased research into cannabis as a treatment for illness and a variety of health conditions.


However, international governance of medical cannabis is not expected to relax. 


“While the move doesn’t totally free the plant from treaty control, it’s a giant step toward the normalization of cannabis in medicine above all but also in our societies generally,” said Kenzi Riboulet-Zemouli, an independent researcher at the CND.


“Decades of efforts have been necessary to remove cannabis from Schedule IV, with implications that will slowly but surely be seen over the next decades.”


For more interesting cannabis news, stay tuned-in at

Leave a Reply